Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1600 of 3173 entries
View as:

A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01034748 Org: User:
Start: 01/31/10 End: 02/28/10 Due: 02/28/11

A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab

Phase: N/A Priority: Normal
NCT ID: NCT01307267 Org: User:
Start: 06/21/11 End: 02/20/19 Due: 02/20/20

A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST)

Phase: N/A Priority: Normal
NCT ID: NCT00457743 Org: User:
Start: 01/31/05 End: 08/31/08 Due: 08/31/09

A Clinical Trial of the Study Medicine (PF-07081532) in People With Diabetes and Kidney Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT05510245 Org: User:
Start: 08/29/22 End: 07/20/23 Due: 07/20/24

Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

Phase: N/A Priority: Normal
NCT ID: NCT02528188 Org: User:
Start: 07/21/15 End: 02/27/19 Due: 02/27/20

Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults

Phase: N/A Priority: Normal
NCT ID: NCT04370054 Org: User:
Start: 08/18/20 End: 10/25/28 Due: 10/25/29

Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan)

Phase: N/A Priority: Normal
NCT ID: NCT01597258 Org: User:
Start: 05/29/12 End: 03/16/18 Due: 03/16/19

Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR]

Phase: N/A Priority: Normal
NCT ID: NCT00700258 Org: User:
Start: 02/13/08 End: 12/28/21 Due: 12/28/22

Safety, Tolerability and Efficacy of Ceftaroline in Paediatrics With Late-Onset Sepsis

Phase: N/A Priority: Normal
NCT ID: NCT02424734 Org: User:
Start: 08/04/15 End: 12/26/17 Due: 12/26/18

Assessment of Onset, Safety & Toleration of UK-369,003 in Male Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00141349 Org: User:
Start: 02/28/05 End: 08/31/05 Due: 08/31/06

Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail

Phase: N/A Priority: Normal
NCT ID: NCT01278394 Org: User:
Start: 03/31/07 End: 07/31/08 Due: 07/31/09

Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01188668 Org: User:
Start: 08/31/10 End: 10/31/10 Due: 10/31/11

Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00174434 Org: User:
Start: 09/30/05 End: 08/31/07 Due: 08/31/08

A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01212991 Org: User:
Start: 09/16/10 End: 02/14/19 Due: 02/14/20

Bioequivalence Study Of Diltiazem In 60 Mg Tablets As Tilazem 60® Made by Pfizer, S.A. De C.V., Versus Angiotrofin® 60 Mg Made by Amstrong Laboratorios De Mexico, S.A. De C.V.

Phase: N/A Priority: Normal
NCT ID: NCT01151345 Org: User:
Start: 06/30/10 End: 07/31/10 Due: 07/31/11

Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT01994889 Org: User:
Start: 12/09/13 End: 02/07/18 Due: 02/07/19

Study of Fordadistrogene Movaparvovec in Early Stage Duchenne Muscular Dystrophy

Phase: N/A Priority: Normal
NCT ID: NCT05429372 Org: User:
Start: 08/08/22 End: 06/30/25 Due: 06/30/26

A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT01470313 Org: User:
Start: 11/30/11 End: 11/30/13 Due: 11/30/14

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Children With Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT00918580 Org: User:
Start: 11/30/09 End: 03/31/13 Due: 03/31/14

A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.

Phase: N/A Priority: Normal
NCT ID: NCT03580005 Org: User:
Start: 10/31/18 End: 10/12/21 Due: 10/12/22

Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biotherapy in Patients With Rheumatoid Arthritis in Daily Practice

Phase: N/A Priority: Normal
NCT ID: NCT01692899 Org: User:
Start: 06/30/11 End: 09/30/11 Due: 09/30/12

Double-Blind, Double Dummy, Randomized Comparison Study to Evaluate the Efficacy and Safety of Valdecoxib 10 mg Once Daily and Naproxen 500 mg Twice Daily in Treating the Signs and Symptoms of Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT00652808 Org: User:
Start: 05/31/04 End: 09/30/04 Due: 09/30/05

Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT01189461 Org: User:
Start: 01/31/11 End: 07/31/12 Due: 07/31/13

A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.

Phase: N/A Priority: Normal
NCT ID: NCT00139672 Org: User:
Start: 01/31/04 End: 02/28/05 Due: 02/28/06

A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).

Phase: N/A Priority: Normal
NCT ID: NCT02480153 Org: User:
Start: 06/25/15 End: 12/06/17 Due: 12/06/18